Do lung cancer patients need molecular profiling?

Comprehensive molecular profiling of pulmonary pleomorphic ...

Pulmonary pleomorphic carcinoma (PPC) is a rare subtype of non-small cell lung cancer (NSCLC) that accounts for 0.4–1.6% of malignant lung ...

Broad Molecular Profiling | Caris Life Sciences

With the promise of precision medicine becoming a reality, broad molecular profiling has become standard of care for many cancer types – and required for ...

22P Next generation sequencing-based molecular profiling of lung ...

As we showed in our study, the use of targeted NGS panel is a reliable approach for NSCLC molecular profiling and can be applied in personalized treatment ...

Solid Tumor Profiling | A deeper view of variation in solid tumors

In turn, genomic technology has evolved to meet molecular profiling needs. Next-generation sequencing (NGS) provides a comprehensive method for assessing the ...

Molecular Profiling for Supernatants and Matched Cell Pellets of ...

Herein, we included 47 advanced non–small-cell lung cancer patients with PE, who had lung cancer driver mutations tested on tumor tissue ...

Molecular profiles of small cell lung cancer subtypes: Therapeutic ...

Recently, however, substantial progress has been made in our understanding of SCLC biology. Advances in genomics and development of new preclinical models have ...

Lung Cancer - Precision Medicine | AstraZeneca

NCCN Guidelines also recommend broad molecular profiling in eligible patients with metastatic NSCLC to identify all actionable biomarkers. In resectable NSCLC, ...

Molecular Profiling Using Next-generation Sequencing of Sufficient ...

Studies in the United States have shown that approximately one in three lung cancer patients undergo successful next-generation sequencing (NGS) ...

Molecular Profiling Is a Necessity in Colorectal Cancer Treatment

“If someone comes in and [we do not believe their cancer is] metastatic, or if the have had their prior biopsy done at an outside institution, ...

Is molecular profiling useful in the management of breast cancer?

ESMO Guidelines recommend that genomic profiling should only be carried out as part of routine clinical practice if the result will change the ...

Actionable Biomarkers Determined from Broad Molecular Testing for ...

Actionable Biomarkers Determined from Broad Molecular Testing for Patients with Stage IV Non-small Cell Lung Cancer (NSCLC) to Inform Targeted ...

Why Comprehensive Genomic Profiling? - Foundation Medicine

For tumor genomic testing in eligible patients, use of tissue is recommended by professional guidelines, with use of plasma ctDNA (liquid biopsy) assays as an ...

Molecular Analysis for Targeted Therapy of Non-Small Cell Lung ...

guided by available results and, if unknown, these patients are treated as though they do not have driver ... Tumor profiling at the service of ...

Dr. Stein Uses Molecular Testing to Inform His Patients' Cancer ...

NSCLC is a model for molecular testing, with more than 10 non-chemotherapy FDA-approved treatments for those with advanced or metastatic disease. Receiving a ...

Advancements in Immunotherapy a Huge Boon for Lung Cancer ...

“Every patient that has lung cancer should have their tumor completely identified molecularly and genetically,” says Dr. Sonett. “There are a host of new genes ...

Molecular testing in stage I–III non-small cell lung cancer

Should molecular testing be required before neoadjuvant treatment, then this would depend on having obtained a successful biopsy with sufficient tissue for ...

Non-Small Cell Lung Cancer Treatment (PDQ®) - NCI

Pathological staging of NSCLC requires examination of the tumor, knowledge of resection margins, and determination of lymph node status. At ...

Genomic Profiling of Advanced NoneSmall Cell Lung Cancer in ...

Thus, 30 of these patients did not have testing after failure of the first sample, and 7 ... molecular profiling, can be considered to enable more rapid.

Caris Life Sciences: Revolutionizing Cancer Care

Personalized Cancer Care with Molecular Profiling. Knowing what cancer looks like at the molecular level can lead to better treatment options for patients.

How advances in molecular profiling and linked real-world clinico ...

For instance, studies have shown that the majority of patients with advanced non-small cell lung cancer treated in the community setting do not receive all ...